| 期刊全稱 | Behavioral Pharmacology of Neuropeptides: Oxytocin |
| 影響因子2023 | Rene Hurlemann,Valery Grinevich |
| 視頻video | http://file.papertrans.cn/183/182881/182881.mp4 |
| 發(fā)行地址 | Gives insight into a new era of social psychopharmacology based on endogenous neuromodulators.Discusses early-life treatment of social-cognitive deficiencies.Provides cutting-edge information on "prec |
| 學(xué)科分類 | Current Topics in Behavioral Neurosciences |
| 圖書封面 |  |
| 影響因子 | .This volume collects cutting-edge expert reviews in the oxytocin field and will be of interest to a broad scientific audience ranging from social neuroscience to clinical psychiatry. The role of the neuropeptide oxytocin in social behaviors is one of the earliest and most significant discoveries in social neuroscience. Influential studies in animal models have delineated many of the neural circuits and genetic components that underlie these behaviors. These discoveries have inspired researchers to investigate the effects of oxytocin on brain and behavior in humans and its potential relevance as a treatment for psychiatric disorders including borderline personality disorder and autism and schizophrenia spectrum disorders. In fact, there is no established social psychopharmacology in Psychiatry, and oxytocin can be seen as the first endogenous agent specifically addressing social-cognitive impairment in psychiatric disorders, with animal research suggesting that it could be especiallyefficient in the early postnatal period. From a human perspective, it is crucial to understand more precisely who can benefit from potential oxytocin-related treatments, which outcome measures will best |
| Pindex | Book 2018 |
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2026-1-16 22:35
發(fā)表于 2025-3-21 18:26:51
